Cargando…

Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?

The roles that natural killer (NK) cells play in liver disease and transplantation remain ill‐defined. Reports on the matter are often contradictory, and the mechanisms elucidated are complex and dependent on the context of the model tested. Moreover, NK cell attributes, such as receptor protein exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halma, Jennifer, Pierce, Stephen, McLennan, Rebecca, Bradley, Todd, Fischer, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099129/ https://www.ncbi.nlm.nih.gov/pubmed/34866338 http://dx.doi.org/10.1111/cts.13208

Ejemplares similares

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
por: Jiang, Jingyu, et al.
Publicado: (2023)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
por: Rajani, Karishma R., et al.
Publicado: (2015)

Harnessing invariant natural killer T cells to control pathological inflammation
por: Bharadwaj, Nikhila S., et al.
Publicado: (2022)

Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response
por: Pierce, Stephen, et al.
Publicado: (2020)

Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV Infection
por: Alrubayyi, Aljawharah, et al.
Publicado: (2020)

Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
por: Russell, Éilis, et al.
Publicado: (2022)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
por: Liu, Siyao, et al.
Publicado: (2022)

Harnessing the Power of Quality Assurance Data: Can We Use Statistical Modeling for Quality Risk Assessment of Clinical Trials?
por: Koneswarakantha, Björn, et al.
Publicado: (2020)

Development of combinatorial antibody therapies for diffuse large B cell lymphoma
por: Geanes, Eric S., et al.
Publicado: (2022)

Harnessing the power of the Grid
Publicado: (2009)

Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?
por: Aruleba, Raphael Taiwo, et al.
Publicado: (2020)

“We are the ones who will have to make the change”: Cuban health cooperation and the integration of Cuban medical graduates into practice in the Pacific
por: McLennan, Sharon, et al.
Publicado: (2023)

STAT4-associated natural killer cell tolerance following liver transplantation
por: Jamil, K M, et al.
Publicado: (2017)

The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
por: Di Mambro, Tomas, et al.
Publicado: (2019)

Can We Harness “Enviromics” to Accelerate Crop Improvement by Integrating Breeding and Agronomy?
por: Cooper, Mark, et al.
Publicado: (2021)

Harnessing the power of the plasma wakefield
Publicado: (2007)

Harnessing the power of neuroplasticity for intervention
por: Kolb, Bryan, et al.
Publicado: (2014)

Harnessing the power of dividing cardiomyocytes
por: Muralidhar, Shalini A., et al.
Publicado: (2013)

Harnessing the power of microbial nanowires
por: Reguera, Gemma
Publicado: (2018)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Harness the power of the DOI: Digital object identifiers and what they can do for you
por: Young, Sarah
Publicado: (2019)

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
por: Lam, Pui Yeng, et al.
Publicado: (2017)

Entering a new era of harnessing natural killer cell responses in HIV infection
por: Peppa, Dimitra
Publicado: (2019)

Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies
por: St-Pierre, Frederique, et al.
Publicado: (2021)

Learning to Live Together: Harnessing Regulatory T cells to Induce Organ Transplant Tolerance
por: Chang, Andrew Y., et al.
Publicado: (2011)

Complex problems need detailed solutions: Harnessing multiple data types to inform genetic management in the wild
por: Grueber, Catherine E., et al.
Publicado: (2018)

Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
por: Dugast, Emilie, et al.
Publicado: (2017)

Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severity
por: Bradley, Todd, et al.
Publicado: (2023)

The Content and Nature of Narrative Comments on Swiss Physician Rating Websites: Analysis of 849 Comments
por: McLennan, Stuart
Publicado: (2019)

Think twice: harnessing the power of counterintuition
por: Mauboussin, Michael J
Publicado: (2012)

Harnessing solar power: the photovoltaics challenge
por: Zweibel, Ken
Publicado: (1990)

Inescapable data: harnessing the power of convergence
por: Stakutis, Chris, et al.
Publicado: (2005)

Harnessing the power of theorising in implementation science
por: Kislov, Roman, et al.
Publicado: (2019)

Vaccine Vectors Harnessing the Power of Cytomegaloviruses
por: Ynga-Durand, Mario Alberto, et al.
Publicado: (2019)

Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
por: Slepicka, Priscila Ferreira, et al.
Publicado: (2021)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Effects of Prior Infection with SARS-CoV-2 on B Cell Receptor Repertoire Response during Vaccination
por: Fraley, Elizabeth R., et al.
Publicado: (2022)

Corrigendum: Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
por: Dugast, Emilie, et al.
Publicado: (2018)

Clinical Transplantation and Tolerance: Are We There Yet?
por: Saidi, R. F., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tn9m2v21k17rqv71s8osa1p3fu